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DObjective: The aim of the study was to determine whether using the in situ internal thoracic artery (ITA) graft
ipsilateral to the arteriovenous fistula adversely affects the outcomes after isolated coronary artery bypass graft-
ing (CABG) in the dialysis-dependent patients to answer the concerns of a possible steal and consequent myo-
cardial ischemia.
Methods:We categorized 155 dialysis patients undergoing isolated CABG between January 1993 and Decem-
ber 2011 into 108 patients (70%, ipsilateral group) whose left anterior descending artery (LAD) was revascu-
larized with the ITA ipsilateral to the arteriovenous fistula and 47 patients (contralateral group) whose LAD was
grafted with the ITA opposite to the fistula, to compare their early and late outcomes.
Results:While 94% of the ipsilateral group had left fistula, 55% of the contralateral group had left fistulas. The
LAD was grafted with the left ITA in 94% of the ipsilateral group, whereas it was grafted with left (49%) or
right (51%) ITAs in the contralateral group. There was no significant difference in hospital mortality between
the groups (ipsilateral 10.2% vs contralateral 10.6%). After follow-up for 55  42 months, the overall survival
(ipsilateral 58% vs contralateral 65% at 5 years) and cardiac event–free rates (ipsilateral 74% vs contralateral
68% at 5 years) were also similar between the groups by log-rank tests (P ¼ .90 and P ¼ .07).
Conclusions: Revascularization of the LAD using the in situ ITA graft ipsilateral to the arteriovenous fistula
increases neither the operative mortality nor the risks of late death and cardiac events after isolated CABG in
dialysis patients. (J Thorac Cardiovasc Surg 2014;147:619-24)Cardiovascular disease is the principal cause of deaths in pa-
tients receiving hemodialysis (HD), more than two thirds of
whom have symptomatic coronary artery disease.1-3
Increased population with renal disease and extended life
expectancy of HD patients result in more HD patients,
especially with diabetes mellitus (DM) and advanced age,
referred for coronary revascularization. For the HD patients
with multivessel disease, coronary artery bypass grafting
(CABG) may be selected on the basis of the guidelines and
the previous studies demonstrating the superiority of
CABG to percutaneous coronary intervention.4-7 As well
as in non-HD patients, in situ internal thoracic artery (ITA)
grafting to the left anterior descending artery (LAD) im-
proves survival and freedom from major adverse cardiac
events (MACE) in HD patients.8-11
However, there are concerns of a possible steal in HD pa-
tients with a functioning ITA graft and an ipsilateral arterio-
venous (AV) fistula or shunt of the upper extremity.12-15
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The Journal of Thoracic and Caartery steal with an ipsilateral AV fistula, there have been
several reports of a steal and consequent myocardial
ischemia during HD. The aim of the present study was to
determine whether revascularization of the LAD using the
in situ ITA graft ipsilateral to the AV fistula increases the
risk of late death and MACE after isolated CABG in HD
patients.
METHODS
The institutional review board approved this retrospective observational
study, and the approval included a waiver of informed consent.
Study Patients
We performed isolated CABG in 159 patients with end-stage renal fail-
ure requiring HD (124men and 35 womenwith a mean age of 63 8 years)
over an 18-year period between January 1993 and December 2011. They
comprised 10.4% of all patients undergoing isolated CABG during the
same period. They had a history of HD for 8.9  8.1 years (range,
0.2-36 years). The major causes of end-stage renal failure included chronic
glomerulonephritis (n ¼ 32, 20%) and DM (n ¼ 86, 54%), whereas the
causes of disease in 17 (11%) patients were unknown.
Among them, after excluding 4 patients who did not undergo ITA graft-
ing to the LAD, 155 patients were included in the study to compare 108 pa-
tients (69.7%, ipsilateral group) whose LADwas revascularized with the in
situ ITA ipsilateral to the AV fistula and 47 patients (30.3%, contralateral
group) whose LAD was revascularized with the in situ ITA opposite to the
AV fistula.
CABG and Perioperative Renal Management
Surgical procedures of CABG were performed through a median ster-
notomy, after low-potassium (1.5 mEq/L) HD for the consecutive 2 days,rdiovascular Surgery c Volume 147, Number 2 619
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Dexcept for emergency cases, to obtain serum potassium of 3.0 mEq/L.16 In
our strategy, in situ bilateral ITAs were preferred for revascularization of
the left coronary territory whenever possible anatomically. Right ITAs
were used to revascularize the LAD by crossing the midline if necessary.
However, the use of bilateral ITAs was avoided in the HD patients with
DM owing to the concerns of postoperative mediastinitis. The gastroepi-
ploic artery (GEA) was mostly used for revascularization of the right cor-
onary arteries with more than 90% stenosis. The coronary arteries, for
which ITAs and gastroepiploic arteries were not used, were bypassed using
saphenous veins anastomosed with the ascending aorta.
Since 2003, CABG was preferably performed on the beating heart with
off-pump technique and cardiopulmonary bypass (CPB) was used if neces-
sary. When CPB was used, we performed only hemofiltration during CPB,
as in non-HD patients. By means of a hemoconcentrator incorporated into
the CPB circuit, serum potassium less than 4.0 mEq/L and blood hemoglo-
bin greater than 10.0 g/dL were maintained at the end of CPB to prevent
subsequent hyperkalemia.16 HD was resumed on the first postoperative
day in most patients, except for those with hemodynamic instability or ad-
vanced hyperkalemia, who alternatively underwent continuous venove-
nous hemofiltration.
Data Collection and Follow-up
The ipsilateral and contralateral groups were retrospectively compared
regarding the following primary end points: hospital mortality, late overall
death, and late MACE. Hospital mortality was defined as death for any rea-
son during the same hospitalization regardless of the length. Follow-up data
were obtained from hospital charts or follow-up physicians and by means
of direct telephone interviews with the patients or their families. The
MACE was defined as cardiac death, myocardial infarction, hospital ad-
mission owing to congestive heart failure, and repeat revascularization.
Cardiac death was defined as any death related to cardiac events, including
sudden death.
Statistical Analysis
Continuous variables were expressed as means  standard deviations
and compared for differences between 2 groups with the Mann-Whitney
U test. Categorical variables were expressed as percentages and analyzed
using the c2 test or Fisher’s exact test where appropriate. A multivariate lo-
gistic regression model was constructed to evaluate whether the side of the
ITAwas an independent predictor of hospital mortality. Long-term survival
and MACE-free rate were estimated using the Kaplan-Meier method. Un-
adjusted comparisons of the 2 groups were made with a log-rank test. Cox
proportional hazards models were also constructed to evaluate the effect of
the side of ITA in the presence of potentially confounding covariates. All
statistical analyses were performed with IBM SPSS Statics version 19620 The Journal of Thoracic and Cardiovascular Surg(IBM Corporation, Armonk, NY), calculating hazard ratios (HR), 95%
confidence intervals (CI), and levels of statistical significance.
RESULTS
Preoperative and Operative Characteristics
As shown in Table 1, there were no significant differences
in the patient characteristics, with the exception of the side
of AV fistula, between the ipsilateral and contralateral
groups. Whereas 94% of the ipsilateral group had left AV
fistula, 55% of the contralateral group had left AV fistulas
(P<.001). The locations and constructions of AV fistulas
were similar between the 2 groups.
As shown in Table 2, the study patients underwent con-
ventional (n ¼ 55, 34%), on-pump beating heart (n ¼ 31,
20%) or off-pump coronary artery bypass (n ¼ 71, 46%)
with distal anastomoses of 2.9  0.9 per patient, with no
significant differences between the 2 groups. With regard
to the graft arrangements, in situ left ITAs were used in
all patients of the ipsilateral group and were mainly grafted
to the LAD. In contrast, left ITAs were used in 91% of the
patients of the contralateral group and were mostly grafted
to the LAD or left circumflex artery. Right ITAs were more
frequently used in the contralateral group than the ipsilat-
eral group (60% vs 24%; P < .001). Right ITAs were
mainly anastomosed to the left circumflex artery in the ipsi-
lateral group and to the LAD in the contralateral group. No
free ITA grafts were used for the non-LAD coronary ar-
teries. Consequently, bilateral in situ ITAs were used
more frequently in the contralateral group than in the ipsi-
lateral group (47% vs 24%; P ¼ .004). There were no sig-
nificant differences in the use of gastroepiploic artery and
saphenous vein graft between the 2 groups.
Early Outcomes
Hospital mortality was 10.3% (16/155). The mortality
improved over time: 16.2% (11/68) before 2003 and
5.7% (5/87) after 2003. The causes of hospital death in-
cluded mediastinitis (n ¼ 5), cardiac-related (n ¼ 4), sepsis
(n ¼ 3), pneumonia (n ¼ 2), gastrointestinal ischemia
(n ¼ 1), and stroke (n ¼ 1). As shown in Table 3, there
were no significant differences in the hospital mortality
and the occurrence of postoperative complications, includ-
ing mediastinitis and stroke, between the ipsilateral and
contralateral groups. There were also no significant differ-
ences in the durations of intensive care unit stay and hospi-
tal stay between the survivors of the 2 groups.
A multivariate logistic regression analysis adjusting for 5
covariates, including left ventricular ejection fraction
(LVEF) less than 40%, CPB use, bilateral ITA, and postop-
erative mediastinitis, revealed that ipsilateral ITA grafting
to the LAD was no longer a predictor for hospital mortality
(HR, 0.86; 95% CI, 0.49-1.50; P¼ .59). However, the vari-
ables of LVEF less than 40% (HR, 2.22; 95% CI,
1.23-7.12; P ¼ .03) and CPB use (HR, 3.27; 95% CI,ery c February 2014
TABLE 1. Patients characteristics of 155 HD patients undergoing
isolated CABG according to the side of AV fistula and the side of
ITA grafted with the LAD
Ipsilateral
(n ¼ 108)
Contralateral
(n ¼ 47) P value
Age, y 63  8 63  9 1.00
Male, n (%) 88 (81%) 34 (72%) .12
HD duration, y 8.8  7.6 9.1  9.0 .83
Hypertension, n (%) 79 (73%) 35 (75%) .86
DM, n (%) 59 (55%) 25 (53%) .84
Hyperlipidemia, n (%) 41 (38%) 19 (40%) .70
Smoking, n (%) 69 (64%) 29 (62%) .89
PAD, n (%) 33 (31%) 15 (32%) .72
Previous CVD, n (%) 18 (17%) 7 (15%) .63
Previous MI, n (%) 35 (32%) 13 (28%) .53
History of HF, n (%) 39 (36%) 15 (32%) .56
LVEF,% 54  15 54  17 1.00
Side of AV fistula, n (%) <.001
Right 6 (6%) 21 (45%)
Left 102 (94%) 26 (55%)
Location of AV fistula, n (%) .57
Upper arm 11 (10%) 7 (15%)
Forearm 97 (90%) 40 (85%)
Construction of AV fistula, n (%) .95
Direct anastomosis 94 (87%) 40 (85%)
Prosthetic graft 14 (13%) 7 (15%)
HD, Hemodialysis; CABG, coronary artery bypass grafting; AV, arteriovenous; ITA,
internal thoracic artery; LAD, left anterior descending artery; DM, diabetes mellitus;
PAD, peripheral artery disease; CVD, cerebrovascular disease;MI, myocardial infarc-
tion; HF, heart failure; LVEF, left ventricular ejection fraction.
TABLE 2. Operative data
Ipsilateral
(n ¼ 108)
Contralateral
(n ¼ 47) P value
Emergency, n (%) 24 (22%) 11 (23%) .93
CABG .79
Conventional, n (%) 41 (38%) 12 (26%)
On-pump beating, n (%) 18 (17%) 13 (27%)
Off-pump, n (%) 49 (45%) 22 (47%)
Anastomosis 2.8  1.0 2.9  0.9 .55
LITA use, n (%) 108 (100%) 43 (91%) .002
To LAD, n (%) 101 (93%) 21 (45%) <.001
To diagonal branch, n (%) 11 (10%) 10 (21%) .10
To LCX, n (%) 8 (7%) 22 (47%) <.001
Sequential, n (%) 16 (15%) 12 (24%) .13
RITA use, n (%) 26 (24%) 28 (60%) <.001
To LAD, n (%) 5 (5%) 22 (47%) <.001
To diagonal branch, n (%) 1 (1%) 3 (6%) .06
To LCX, n (%) 14 (13%) 5 (11%) .46
To RCA, n (%) 7 (6%) 2 (4%) .51
Sequential, n (%) 2 (2%) 6 (13%) .004
GEA use, n (%) 27 (25%) 10 (20%) .45
To LCX, n (%) 5 (5%) 1 (2%) .41
To RCA, n (%) 25 (23%) 10 (20%) .62
Sequential, n (%) 5 (5%) 2 (4%) .84
SVG use, n (%) 66 (61%) 27 (53%) .33
To diagonal branch, n (%) 9 (8%) 3 (6%) .31
To LCX, n (%) 42 (39%) 11 (23%) .06
To RCA, n (%) 52 (48%) 23 (45%) .89
Sequential, n (%) 37 (34%) 10 (20%) .09
Bilateral ITA use, n (%) 27 (25%) 22 (47%) .004
All arterial conduits, n (%) 42 (39%) 24 (51%) .15
CABG, Coronary artery bypass grafting; LITA, left internal thoracic artery; LAD, left
anterior descending artery; LCX, left circumflex artery; RITA, right internal thoracic
artery; RCA, right coronary artery; SVG, saphenous vein graft; ITA, internal thoracic
artery; GEA, gastroepiploic artery.
TABLE 3. Early outcomes
Ipsilateral
(n ¼ 108)
Contralateral
(n ¼ 47) P value
Hospital death, n (%) 11 (10.2%) 5 (10.6%) .93
Cardiac 3 1 .63
Non-cardiac 8 4
Mediastinitis, n (%) 13 (12.0%) 8 (17.0%) .40
CVVH use, n (%) 16 (14.8%) 11 (23.4%) .19
Stroke, n (%) 2 (1.9%) 1 (2.0%) .96
Survivors
ICU stay, d (median) 2.7  6.5 (2) 3.1  5.1 (2) .67
Hospital stay, d (median) 28  33 (18) 35  42 (19) .30
CVVH, Continuous veno-venous hemofiltration; ICU, intensive care unit.
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D1.18-7.85; P ¼ .04) emerged as predictor of hospital
mortality.
Late Outcomes
During the follow-up period of 55 42 months (median,
4.2 years) for 139 survivors, 58 (42%) patients died and 42
(30%) had MACE. The causes of late death included car-
diac (n¼ 24, 41%), gastrointestinal (n¼ 8, 14%), infection
(n ¼ 8, 14%), stroke (n¼ 7, 12%), exacerbation of periph-
eral artery disease (n ¼ 5), cancer (n ¼ 5), and unknown
(n ¼ 1). The overall actuarial survivals were 76.9% and
60.0% at 3 and 5 years, respectively. Median survival was
7.0 years. The MACE-free rates were 77.0% and 70.1%
at 3 and 5 years, respectively. Among them, 102 (73%) pa-
tients, 97 (75%) in the ipsilateral group and 29 (70%) in the
contralateral group, used the AV fistula of the same side dur-
ing the follow-up period, whereas the others switched to HD
through a contralateral side fistula. According to the side of
AV fistula, overall survival estimates were similar between
the ipsilateral and contralateral groups (P ¼ .90), as shown
in Figure 1. Also, there was no statistically significant dif-
ference in MACE-free rate between the 2 groups
(P ¼ .07), as shown in Figure 2.
A Cox proportional hazards model adjusting for 6 cova-
riates, including age greater than 65 years, DM, peripheralThe Journal of Thoracic and Caartery disease, LVEF less than 40%, and postoperative me-
diastinitis, revealed that ipsilateral ITA grafting to the LAD
was not a predictor for late death (Table 4). The variables of
age less than 65 years, DM, and peripheral artery disease
emerged as statistically significant predictors of late death.
Also, after adjusting for 6 covariates, DM, LVEF less thanrdiovascular Surgery c Volume 147, Number 2 621
FIGURE 1. Estimated overall survival in the Kaplan-Meier model for
patients whose left anterior descending artery (LAD) was revascularized
with the internal thoracic artery (ITA) ipsilateral to the arteriovenous fistula
(ipsilateral group, dotted line) and patients whose LAD was grafted with
the ITA opposite to the fistula (contralateral group, solid line).
TABLE 4. Predictors for late death and MACE
Hazard ratio 95% CI P value
All-cause death
Age>65 y 1.84 1.65-5.23 .035
Diabetes mellitus 3.14 1.51-6.53 .002
PAD 1.27 1.07-8.64 .042
LVEF<40% 0.99 0.98-1.01 .586
Postoperative mediastinitis 1.072 0.46-2.51 .873
Ipsilateral ITA graft to LAD 0.53 0.24-1.17 .227
MACE
Diabetes mellitus 3.11 1.50-6.45 .004
LVEF<40% 2.46 1.18-8.43 .036
SVG use 0.93 0.47-1.82 .421
CPB use 1.08 0.38-2.51 .755
Ipsilateral ITA graft to LAD 0.73 0.24-1.84 .114
MACE, Major adverse cardiac events; CI, confidence interval; PAD, peripheral artery
disease; LVEF, left ventricular ejection fraction; ITA, internal thoracic artery; LAD,
left anterior descending artery; SVG, saphenous vein graft; CPB, cardiopulmonary
bypass.
Acquired Cardiovascular Disease Takami et al
A
C
D40%, use of saphenous vein graft, ipsilateral ITA grafting to
the LAD was not a predictor for late MACE. DM and LVEF
less than 40% were the independent predictors of late
MACE.FIGURE 2. Estimated freedom from major adverse cardiac events
(MACE) in the Kaplan-Meier model for patients whose left anterior
descending artery (LAD) was revascularized with the internal thoracic
artery (ITA) ipsilateral to the arteriovenous fistula (ipsilateral group,
dotted line) and patients whose LAD was grafted with the ITA opposite
to the fistula (contralateral group, solid line).
622 The Journal of Thoracic and Cardiovascular SurgDISCUSSION
The key finding of this study was that revascularization of
the LAD using the ITA graft ipsilateral to the AV fistula rai-
ses neither the operative mortality nor the risks of late death
and MACE after isolated CABG in HD patients. We fo-
cused the surgical revascularization of the LAD, which is
the most important for clinical outcomes of the HD patients,
as well as of the non-HD patients. To our knowledge, this is
the first report to assess the effects of the side of ITA graft,
ipsilateral or contralateral to the AV fistula, on outcomes af-
ter CABG. Although no specific investigations of coronary
steal were performed, our results may answer to the con-
cerns of HD-induced reduction of ipsilateral ITA flow as
a potential cause of poor outcomes in HD patients after
CABG.12-15,17-19
In HD patients, the ascending aorta is often subject to
severe atherosclerotic changes, constituting a dangerous
source of systemic emboli after proximal anastomo-
sis.20,21 The use of in situ ITAs is strongly
recommended to minimize aortic manipulation during
CABG. However, Gaudino and colleagues14 showed he-
modynamically evident ITA flow steal and consequent
myocardial hypokinesia on transthoracic echocardiogra-
phy during HD in 5 patients with ipsilateral AV fistula
and ITA graft. In contrast, Rahbar and colleagues22 re-
ported, in 15 HD patients, no significant changes in Dopp-
ler flow of either the ipsilateral or contralateral ITA with
the AV fistula occluded and during HD. According to
the previous reports of survival in HD patients after iso-
lated CABG,12-15,17-19 the 5-year survivals were 50% to
60% and apparently lower than those in non-HD patients.
Our study showed that such poor prognosis of HD patients
is not associated with the side of the ITA graft to the LAD,
which may be closely related to the concerned ITA flow
steal on the same side as the AV fistula.ery c February 2014
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DThe high mortality after CABG in HD patients may result
from more diffuse coronary artery disease with poor runoff.
However, Wong and associates23 quantitatively showed that
HD patients undergoing CABG did not have a greater cor-
onary artery atherosclerosis burden than matched controls.
Therefore, the high mortality in HD patients may attribute
to their extracardiac multiple comorbid disorders, including
ventricular hypertrophy, cerebrovascular and peripheral
artery disease, anemia, infection, electrolyte disturbances,
cachexia, and increase in oxidative stress.24
The first limitation of this study is a retrospective design
with a small sample size and a single-center experience.
This observational study has produced a negative finding
and may be underpowered. A power analysis using Power
and Sample Size Calculation version 3.0 at Vanderbilt Uni-
versity,25 which may be downloaded for free, showed that
a sample size of 159 and 333 patients would have a power
of 0.8 and a value of 5% to detect a 2-year difference in
overall survival and MACE, respectively. Therefore, this
study was underpowered for MACE, but for survival.
Larger prospective studies of HD patients undergoing
CABG are needed to identify risk factors for potential
AV fistula–ITA hemodynamic interference. Second, this
study may not match the patients adequately. Nearly half
of the contralateral group had bilateral ITA use. Our results
may be affected by this difference in bilateral ITA utiliza-
tion. However, our study was conducted on the premise
that coronary steal of the LAD has a much more adverse
effect on the late outcomes than that of the non-LAD ar-
teries. In addition, we should note our finding that late out-
comes of the ipsilateral group are similar to those of the
contralateral group, which included more patients receiv-
ing bilateral ITAs. This finding suggests the less adverse
effects of the ipsilateral ITA use on late outcomes. The
third limitation is that approximately 30% of the study pa-
tients lost functionality of the AV fistula and consequently
switched the side of the fistula over time. The changes of
the side of the AV fistula may affect the results of the pres-
ent study.
As suggested in this study, ITA flow steal may not occur
during HD in a CABG patient with an ipsilateral ITA graft
of average flow. However, we should recognize the risk fac-
tors known to predispose to ITA flow steal, such as altered
ITA anatomy, subclavian stenosis, and anatomic location of
the AV fistula. In addition, we should recognize that the
blood flow through the AV fistula increases with time, asso-
ciated with potential risk of ITA flow steal. Furthermore,
when the long-term HD patients require additional AV fis-
tulas, we must consider what kind of graft conduit is
used. On the other hand, as Baciewicz and Harris12 and Ba-
ciewicz alone15 recommend, an AV fistula with high flow
volume, for example, a bridge fistula with a prosthetic graft
or more proximal fistula in the upper extremity, should not
be constructed in patients with ipsilateral ITA grafts.The Journal of Thoracic and CaIn conclusion, revascularization of the LAD using an in
situ ITA graft ipsilateral to the AV fistula increases neither
the operative mortality nor the risks of late death and
MACE after isolated CABG in HD patients. Our results
may provide important information regarding the choice
of CABG graft conduits and the management of the HD
patients after CABG.References
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